about
Melatonin acts as antioxidant and improves sleep in MS patients.Effect of high glucose concentrations on human erythrocytes in vitroGlycation of bovine serum albumin by ascorbate in vitro: Possible contribution of the ascorbyl radical?Oxidative modification of proteins in pediatric cystic fibrosis with bacterial infections.Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products.Posttranslational protein modifications by reactive nitrogen and chlorine species and strategies for their prevention and elimination.Prevention of protein glycation by natural compounds.Developmental changes in the levels and redox potentials of main hemolymph thiols/disulfides in the Jamaican field cricket Gryllus assimilis.Anticancer agent 3-bromopyruvic acid forms a conjugate with glutathione.Effect of glycation inhibitors on aging and age-related diseases.Is Iron Chelation Important in Preventing Glycation of Bovine Serum Albumin in Vitro?Effect of antioxidants supplementation on aging and longevityAscorbic acid and protein glycation in vitro.Role of melatonin receptor MT(2) and quinone reductase II in the regulation of the redox status of 3T3-L1 preadipocytes in vitro.Oxidative modification of blood serum proteins in multiple sclerosis after interferon or mitoxantrone treatment.Effect of 3-bromopyruvate acid on the redox equilibrium in non-invasive MCF-7 and invasive MDA-MB-231 breast cancer cells.Nitroxides protect against peroxynitrite-induced nitration and oxidation.Oxidative Modification of Blood Serum Proteins in Multiple Sclerosis after Interferon Beta and Melatonin Treatment.Superoxide dismutase protects ribonucleotide reductase from inactivation in yeast.Tempo-phosphate as an ESR tool to study phosphate transport.Antioxidant properties of catechins: Comparison with other antioxidants.ABCB1-overexpressing MDCK-II cells are hypersensitive to 3-bromopyruvic acid.Oxidative modifications of blood serum proteins in myasthenia gravis.Glutathione is the main endogenous inhibitor of protein glycation.Antioxidant properties of atypical antipsychotic drugs used in the treatment of schizophrenia.Oxidative Stress Markers Patients with Parotid Gland Tumors: A Pilot Study.Modification of the deoxyribose test to detect strong iron binding.Origin and pathophysiology of protein carbonylation, nitration and chlorination in age-related brain diseases and aging.Dimethyl sulfoxide induces oxidative stress in the yeast Saccharomyces cerevisiaeRedox nanoparticles: synthesis, properties and perspectives of use for treatment of neurodegenerative diseasesRole of Oxidative, Nitrative, and Chlorinative Protein Modifications in Aging and Age-Related DiseasesKinetics of glycoxidation of bovine serum albumin by methylglyoxal and glyoxal and its prevention by various compounds.Oxidative modification of serum proteins in multiple sclerosisNitroxides prevent protein glycoxidation in vitroKinetics of glycoxidation of bovine serum albumin by glucose, fructose and ribose and its prevention by food componentsEffect of 3-bromopyruvic acid on human erythrocyte antioxidant defense systemTransport of 3-bromopyruvate across the human erythrocyte membraneProtection against peroxynitrite reactions by flavonoidsFlavanols protect the yeast Saccharomyces cerevisiae against heating and freezing/thawing injuryInteraction of Catechins with Human Erythrocytes
P50
Q34006944-917C93D8-5C99-4468-A442-C553017AB4FAQ35864917-578252A1-E8CE-41B2-B1B7-BA2CC377208FQ35909483-4C6EE6BB-2693-4D38-A8E1-9C72AB8AA1D0Q37719105-935C6647-4EB7-4C45-8833-B3485A6C5C41Q38096444-C4DE08C9-14DF-483A-B70E-8E5C08217B20Q38239610-6D879C92-85AC-4CCB-BE9E-DC5896F65718Q38358965-C6C38D09-FD17-4A6C-B4DA-CA34A3DEB949Q38660118-818FA293-7512-42CD-B3BA-10BC0E91B339Q38790478-8603C8AE-2DD5-4CED-9992-8200BE7FE7B5Q38965349-A3BC43E7-B0F9-45D1-87ED-6862A42E5E4DQ40767162-DBA3A76C-5F2C-41C0-AA16-3D554E7C475CQ41890789-EB80653D-B7E0-4488-BA01-96CBB15D326EQ42701220-EE5AD861-0CB2-4109-8228-74A4A99F3666Q42712090-1D78C5C9-72EC-4C3E-BBC8-12546803B30BQ43916759-8B2AF2DC-009E-4CD5-83A5-6BBD6E68DD8BQ46617301-01D908B0-566A-42A5-AF0F-7D9CE0E017F2Q46642494-FF64A3D7-D620-44E2-8ED3-BDF04357DF94Q47133556-D6D3C9DC-653D-4B2A-AC66-C3FFAF5485B9Q47228095-E3E70D41-20ED-41F4-9398-6A0FC6B70CD4Q47623430-BFC9137C-21CE-4357-8384-1B4B88B94CCBQ49666389-1F506A8F-C865-4E4B-B228-E1E9F376D3FDQ50230685-04FE7F90-F647-41F5-A47D-C52551339B58Q51101712-F2CC89AB-CE38-4FE1-A01B-4B3E0E24AC9DQ51130574-289CE42E-F775-46A0-BAAB-E8A66A24D4B2Q51622554-AEFF2ED8-C43C-419D-9B69-4F1100A40FEBQ52590665-DE172097-30B2-4D4D-B043-AAFDE75B616BQ52774662-9D527414-91FE-4DD5-B655-B6D9B4E0619EQ55262112-4B9D95A2-D6EA-4D76-8DA6-1E00201A21E9Q57095965-BF229C19-84F4-43AB-918B-A906F9B2E8C3Q58614416-4F63E9B1-183A-4F4E-A743-26D7532B1DFAQ58796974-ECB5BDD2-EFE5-4B7F-B150-699F165EFDFDQ64902257-5026C2C6-200B-4682-8A77-E3EB3B469CCDQ85772565-31293064-ADAF-4EE0-8EA4-F9D3DF8A861EQ85896777-925BEC3E-4810-46F9-A5FA-1034770DF09BQ86017492-668A0E79-621E-49B6-8633-7894302D9E4BQ87140918-1D076FC2-6B54-4069-A4AF-54C76AE5A9ACQ87642527-68D259D0-3B6A-4345-A055-58FA8DCC1677Q88220253-68F1A15C-0A0B-4CC3-AFBB-D64BE7010137Q90297901-42A4BD8B-C2EF-4A2E-8630-B1194769C2EFQ90662414-9801351F-B953-47F1-9F1C-D36E3AD8B89E
P50
description
researcher ORCID ID = 0000-0001-9035-6833
@en
wetenschapper
@nl
name
Izabela Sadowska-Bartosz
@ast
Izabela Sadowska-Bartosz
@en
Izabela Sadowska-Bartosz
@es
Izabela Sadowska-Bartosz
@nl
type
label
Izabela Sadowska-Bartosz
@ast
Izabela Sadowska-Bartosz
@en
Izabela Sadowska-Bartosz
@es
Izabela Sadowska-Bartosz
@nl
prefLabel
Izabela Sadowska-Bartosz
@ast
Izabela Sadowska-Bartosz
@en
Izabela Sadowska-Bartosz
@es
Izabela Sadowska-Bartosz
@nl
P106
P1153
55802850600
P31
P496
0000-0001-9035-6833